Floatz logo

112 assets in Hormone Receptor-Positive Breast Cancer

Therapeutic assets addressing Hormone Receptor-Positive Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Everolimus
Hormone Receptor-Positive Breast Cancer
Ellipses PharmaP4BBB (75)
Exemestane
Hormone Receptor-Positive Breast Cancer
Fujian Cancer HospitalP4BBB (75)
Anastrozole
Hormone Receptor-Positive Breast Cancer
University of Illinois at ChicagoP4BBB (74)
Palbociclib
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP3BBB (73)
Ribociclib
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP4BBB (73)
Abemaciclib
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP4BBB (72)
Capecitabine
Hormone Receptor-Positive Breast Cancer
Kristina A. FanucciP4BBB (72)
Carboplatin
Hormone Receptor-Positive Breast Cancer
Avenzo Therapeutics, Inc.P3BB (70)
Elacestrant
Hormone Receptor-Positive Breast Cancer
West German Study GroupP3BB (70)
Fulvestrant
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP4BB (70)
Trastuzumab
Hormone Receptor-Positive Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (70)
Letrozole
Hormone Receptor-Positive Breast Cancer
Universitaire Ziekenhuizen KU LeuvenP4BB (69)
Pertuzumab
Hormone Receptor-Positive Breast Cancer
Baylor Breast Care CenterP3BB (68)
Tamoxifen
Hormone Receptor-Positive Breast Cancer
Fujian Cancer HospitalP3BB (67)
Epirubicin
Hormone Receptor-Positive Breast Cancer
First Affiliated Hospital of Zhejiang UniversityP3BB (65)
Revaree Plus
Hormone Receptor-Positive Breast Cancer
Memorial Sloan Kettering Cancer CenterP4BB (65)
Bgb-43395
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP3BB (64)
Capivasertib
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.P3BB (64)
Eribulin
Hormone Receptor-Positive Breast Cancer
Hunan Cancer HospitalP2BB (64)
Pembrolizumab
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.P2BB (64)
Pyrotinib
Hormone Receptor-Positive Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
Cyclophosphamide
Hormone Receptor-Positive Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3B (63)
Durvalumab
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P3B (63)
Goserelin
Hormone Receptor-Positive Breast Cancer
Mayo ClinicP3B (63)
Docetaxel
Hormone Receptor-Positive Breast Cancer
The First Affiliated Hospital with Nanjing Medical UniversityP3B (62)
Toripalimab
Hormone Receptor-Positive Breast Cancer
First Affiliated Hospital of Zhejiang UniversityP3B (62)
Adebrelimab
Hormone Receptor-Positive Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (60)
Disitamab Vedotin
Hormone Receptor-Positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP3B (60)
Trastuzumab Deruxtecan
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P2B (60)
Tucidinostat
Hormone Receptor-Positive Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Hydroxychloroquine
Hormone Receptor-Positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP3B (58)
Rivoceranib
Hormone Receptor-Positive Breast Cancer
Fudan UniversityP3B (57)
Fruquintinib
Hormone Receptor-Positive Breast Cancer
Immunitas TherapeuticsP1/2CCC (55)
Nivolumab
Hormone Receptor-Positive Breast Cancer
Fred Hutchinson Cancer CenterP1/2CCC (55)
Alpelisib
Hormone Receptor-Positive Breast Cancer
Marina N SharifiP2CCC (53)
Amiloride
Hormone Receptor-Positive Breast Cancer
Laura Huppert, MD, BAP2CCC (53)
arx788
Hormone Receptor-Positive Breast Cancer
Laura Huppert, MD, BAP2CCC (53)
Benmelstobart
Hormone Receptor-Positive Breast Cancer
First Affiliated Hospital of Zhejiang UniversityP2CCC (53)
Binimetinib
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
c105
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
Camizestrant
Hormone Receptor-Positive Breast Cancer
MedSIRP2CCC (53)
Catequentinib
Hormone Receptor-Positive Breast Cancer
First Affiliated Hospital of Zhejiang UniversityP2CCC (53)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
Colesevelam
Hormone Receptor-Positive Breast Cancer
Spanish Breast Cancer Research GroupP2CCC (53)
Degarelix
Hormone Receptor-Positive Breast Cancer
Jose Pablo LeoneP2CCC (53)
ds-8201a
Hormone Receptor-Positive Breast Cancer
MedSIRP2CCC (53)
Etoposide
Hormone Receptor-Positive Breast Cancer
Hunan Cancer HospitalP2CCC (53)
Fes F-18
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
FFNP
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
Fludeoxyglucose
Hormone Receptor-Positive Breast Cancer
University of WashingtonP2CCC (53)
Showing 1 to 50 of 112 assets
PreviousPage 1 of 3Next